These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. Muraoka RS; Lenferink AE; Law B; Hamilton E; Brantley DM; Roebuck LR; Arteaga CL Mol Cell Biol; 2002 Apr; 22(7):2204-19. PubMed ID: 11884607 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. Vlach J; Hennecke S; Amati B EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653 [TBL] [Abstract][Full Text] [Related]
6. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Benaud CM; Dickson RB Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151 [TBL] [Abstract][Full Text] [Related]
7. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells. Lu Y; Zi X; Pollak M Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698 [TBL] [Abstract][Full Text] [Related]
9. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells. Delmas C; Manenti S; Boudjelal A; Peyssonnaux C; Eychène A; Darbon JM J Biol Chem; 2001 Sep; 276(37):34958-65. PubMed ID: 11418594 [TBL] [Abstract][Full Text] [Related]
10. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells. Bhatia N; Agarwal C; Agarwal R Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294 [TBL] [Abstract][Full Text] [Related]
11. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2. Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487 [TBL] [Abstract][Full Text] [Related]
12. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Cheng M; Sexl V; Sherr CJ; Roussel MF Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290 [TBL] [Abstract][Full Text] [Related]
13. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency. Lane HA; Beuvink I; Motoyama AB; Daly JM; Neve RM; Hynes NE Mol Cell Biol; 2000 May; 20(9):3210-23. PubMed ID: 10757805 [TBL] [Abstract][Full Text] [Related]
14. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells. Taipale M; Tiihonen E; Heiskanen A; Laiho M Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583 [TBL] [Abstract][Full Text] [Related]
15. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes. Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells. Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963 [TBL] [Abstract][Full Text] [Related]
17. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939 [TBL] [Abstract][Full Text] [Related]
18. Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells. D'Alessio A; De Luca A; Maiello MR; Lamura L; Rachiglio AM; Napolitano M; Gallo M; Normanno N Breast Cancer Res Treat; 2010 Sep; 123(2):387-96. PubMed ID: 19946741 [TBL] [Abstract][Full Text] [Related]
19. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577 [TBL] [Abstract][Full Text] [Related]
20. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Shin I; Yakes FM; Rojo F; Shin NY; Bakin AV; Baselga J; Arteaga CL Nat Med; 2002 Oct; 8(10):1145-52. PubMed ID: 12244301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]